UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 59.

Aebi-Popp, K; Kouyos, R; Bertisch, B; Staehelin, C; Rudin, C; Hoesli, I; Stoeckle, M; Bernasconi, E; Cavassini, M; Grawe, C; Lecompte, T D; Rickenbach, M; Thorne, C; Martinez de Tejada, B; Fehr, J (2016). Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period. HIV Medicine, 17(4):280-288.

Hasse, B; Iff, M; Ledergerber, B; Calmy, A; Schmid, P; Hauser, C; Cavassini, M; Bernasconi, E; Marzolini, C; Tarr, P E; Aubert, V; Barth, J; Battegay, M; Bernasconi, E; Boni, J; Bucher, H C; Burton-Jeangros, C; Calmy, A; Cavassini, M; Egger, M; Elzi, L; Fehr, J; Fellay, J; Furrer, H; Fux, C A; Gorgievski, M; Gunthard, H; Haerry, D; Hasse, B; Hirsch, H H; Hosli, I; Kahlert, C; Kaiser, L; Keiser, O; Klimkait, T; Kouyos, R; Kovari, H; Ledergerber, B; Martinetti, G; Martinez de Tejada, B; Metzner, K; Muller, N; Nadal, D; Pantaleo, G; Rauch, A; Regenass, S; Rickenbach, M; Rudin, C; Schoni-Affolter, F; Schmid, P; Schultze, D; Schupbach, J; Speck, R; Staehelin, C; Tarr, P; Telenti, A; Trkola, A; Vernazza, P; Weber, R; Yerly, S (2014). Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV cohort study. Open Forum Infectious Diseases, 1(2):ofu040.

Weber, R; Ruppik, M; Rickenbach, M; Spoerri, A; Furrer, H; Battegay, M; Cavassini, M; Calmy, A; Bernasconi, E; Schmid, P; Flepp, M; Kowalska, J; Ledergerber, B; Schmid, P; Schultze, D; Schöni-Affolter, F; Schüpbach, J; Speck, R; Taffé, P; Tarr, P; Telenti, A; Trkola, A; Vernazza, P; Weber, R; Yerly, S (2013). Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Medicine, 14(4):195-207.

Stern, M; Czaja, K; Rauch, A; Rickenbach, M; Günthard, H F; Battegay, M; Fellay, J; Hirschel, B; Hess, C (2012). HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruption. HIV Medicine, 13(10):589-595.

Young, J; Scherrer, A; Günthard, H; Opravil, M; Yerly, S; Böni, J; Rickenbach, M; Fux, C; Cavassini, M; Bernasconi, E; Vernazza, P; Hirschel, B; Battegay, M; Bucher, H (2011). Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Medicine, 12(5):299-307.

Schüpbach, J; Bisset, L R; Regenass, S; Bürgisser, P; Gorgievski, M; Steffen, I; Andreutti, C; Martinetti, G; Shah, C; Yerly, S; Klimkait, T; Gebhardt, M; Schöni-Affolter, F; Rickenbach, M (2011). High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC Infectious Diseases, 11(1):254.

Ledergerber, B; Cavassini, M; Battegay, M; Bernasconi, E; Vernazza, P; Hirschel, B; Furrer, H; Rickenbach, M; Weber, R (2011). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV Medicine, 12(5):279-288.

Glass, T R; Battegay, M; Cavassini, M; De Geest, S; Furrer, H; Vernazza, P L; Hirschel, B; Bernasconi, E; Rickenbach, M; Günthard, H F; Bucher, H C (2010). Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 54(2):197-203.

Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B; Keiser, O; Swiss HIV Cohort Study (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British Journal of Cancer, 103(3):416-422.

Schoeni-Affolter, F; Ledergerber, B; Rickenbach, M; Rudin, C; Günthard, H F; Telenti, A; Furrer, H; Yerly, S; Francioli, P (2010). Cohort profile: the Swiss HIV Cohort study. International Journal of Epidemiology, 39(5):1179-1189.

Weber, R; Sabin, C; Reiss, P; De Wit, S; Worm, S W; Law, M; Dabis, F; D'Arminio Monforte, A; Fontas, E; El-Sadr, W; Kirk, O; Rickenbach, M; Phillips, A; Ledergerber, B; Lundgren, J (2010). HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D cohort study. Antiviral Therapy, 15(8):1077-1086.

Sullivan, S G; Hirsch, H H; Franceschi, S; Steffen, I; Amari, E B E; Mueller, N J; Magkouras, I; Biggar, R J; Rickenbach, M; Clifford, G M (2010). Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study. AIDS, 24(14):2245-2252.

Rudin, C; Wolbers, M; Nadal, D; Rickenbach, M; Bucher, H C (2010). Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children. Archives of Disease in Childhood, 95(6):478-481.

Audigé, A; Taffé, P; Rickenbach, M; Battegay, M; Vernazza, P; Nadal, D; Speck, R (2010). Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors. AIDS Research and Human Retroviruses, 26(9):997-1005.

Kouyos, R D; von Wyl, V; Yerly, S; Böni, J; Taffé, P; Shah, C; Bürgisser, P; Klimkait, T; Weber, R; Hirschel, B; Cavassini, M; Furrer, H; Battegay, M; Vernazza, P L; Bernasconi, E; Rickenbach, M; Ledergerber, B; Bonhoeffer, S; Günthard, H F (2010). Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. Journal of Infectious Diseases, 201(10):1488-1497.

Osih, R B; Taffé, P; Rickenbach, M; Gayet-Ageron, A; Elzi, L; Fux, C; Opravil, M; Bernasconi, E; Schmid, P; Günthard, H F; Cavassini, M (2010). Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study. AIDS Research and Human Retroviruses, 26(11):1239-1246.

Bucher, H C; Rickenbach, M; Young, J; Glass, T R; Vallet, Y; Bernasconi, E; Cavassini, M; Fux, C; Schiffer, V; Vernazza, P; Weber, R; Battegay, M (2010). Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy. Antiviral Therapy, 15(1):31-40.

Clifford, G M; Rickenbach, M; Lise, M; Dal Maso, L; Battegay, M; Bohlius, J; Boffi El Amari, E; Karrer, Urs; Jundt, G; Bordoni, A; Ess, S; Franceschi, S (2009). Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood, 113(23):5737-5742.

Ballif, M; Ledergerber, B; Battegay, M; Cavassini, M; Bernasconi, E; Schmid, P; Hirschel, B; Furrer, H; Rickenbach, M; Opravil, M; Weber, R (2009). Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PLoS ONE, 4(12):e8275.

Prasad, L; Spicher, V M; Negro, F; Rickenbach, M; Zwahlen, M (2009). Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. Journal of Viral Hepatitis, 16(9):644-649.

Weber, R; Huber, M; Rickenbach, M; Furrer, H; Elzi, L; Hirschel, B; Cavassini, M; Bernasconi, E; Schmid, P; Ledergerber, B (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV Medicine, 10(7):407-416.

Young, J; Bucher, H C; Guenthard, H F; Rickenbach, M; Fux, C A; Hirschel, B; Cavassini, M; Vernazza, P; Bernasconi, E; Battegay, M (2009). Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV. Antiviral Therapy, 14(6):771-779.

Clifford, G M; Rickenbach, M; Polesel, J; Dal Maso, L; Steffen, I; Ledergerber, B; Rauch, A; Probst-Hensch, N M; Bouchardy, C; Levi, F; Franceschi, S (2008). Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS, 22(16):2135-2141.

HIV Cohort Study, Switzerland; von Wyl, V; Yerly, S; Klimkait, T; Böni, J; Bürgisser, P; Battegay, M; Bernasconi, E; Cavassini, M; Furrer, H; Hirschel, B; Vernazza, P L; Rickenbach, M; Ledergerber, B; Guenthard, H F (2008). Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical Infectious Diseases, 46:1299-1309.

Wolbers, M; Bucher, H C; Furrer, H; Rickenbach, M; Cavassini, M; Weber, R; Schmid, P; Bernasconi, E; Hirschel, B; Battegay, M (2008). Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Medicine, 9(6):397-405.

Franceschi, S; Maso, L D; Rickenbach, M; Polesel, J; Hirschel, B; Cavassini, M; Bordoni, A; Elzi, L; Ess, S; Jundt, G; Mueller, N; Clifford, G M; Swiss HIV Cohort Study (2008). Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. British Journal of Cancer, 99(5):800-804.

Polesel, J; Clifford, G M; Rickenbach, M; Dal Maso, L; Battegay, M; Bouchardy, C; Furrer, H; Hasse, B; Levi, F; Probst-Hensch, N M; Schmid, P; Franceschi, S (2008). Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS, 22(2):301-306.

Yerly, S; von Wyl, V; Ledergerber, B; Böni, J; Schüpbach, J; Bürgisser, P; Klimkait, T; Rickenbach, M; Kaiser, L; Günthard, H F; Perrin, L (2007). Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS, 21(16):2223-2229.

von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Furrer, H; Telenti, A; Hirschel, B; Vernazza, P L; Bernasconi, E; Rickenbach, M; Perrin, L; Ledergerber, B; Günthard, H F; Swiss HIV Cohort Study (2007). Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of Internal Medicine, 167(16):1782-1790.

Franceschi, S; Polesel, J; Rickenbach, M; Dal Maso, L; Probst-Hensch, N M; Fux, C; Cavassini, M; Hasse, B; Kofler, A; Ledergerber, B; Erb, P; Clifford, G M (2006). Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. British Journal of Cancer, 95(11):1598-1602.

Böni, J; Schüpbach, J; Rickenbach, M (2006). Rabbit retrotransposon sequences undetectable in blood donors and lymphoma patients of the Swiss HIV Cohort Study. AIDS Research and Human Retroviruses, 22(6):499-500.

Clifford, G M; Polesel, J; Rickenbach, M; Dal Maso, L; Keiser, O; Kofler, A; Rapiti, E; Levi, F; Jundt, G; Fisch, T; Bordoni, A; De Weck, D; Franceschi, S (2005). Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97(6):425-432.

Quattropani, C; Barazzoni, Fabrizio; Rickenbach, M; Wietlisbach, Vincent; Gutzwiller, Felix; Beretta-Piccoli, C; Moccetti, Tiziano; Noseda, G; Domenighetti, Gianfranco; Radaelli, A; Montedoro, E; Dotti, R (1996). Progetto MONICA - evoluzione della terapia dell'infarto miocardico acuto tra il 1986 ed il 1990 nel Cantone Ticino paragonato a risultati nazionali ed internazionali. Tribuna Medica Ticinese, 61:21-29.

Keller, U; Bertel, O; Darioli, R; Epstein, Fred H; Gutzwiller, Felix; Hartmann, G; Mordasini, R; Noseda, G; Pometta, D; Rickenbach, M; Riesen, W; Rutishauser, W (1995). Rolle von Risikofaktoren für die koronare Herzkrankheit. Schweizerische Ärztezeitung (SÄZ), 76(12):497-507.

Burnand, Bernard; Wietlisbach, Vincent; Riesen, W; Noseda, G; Barazzoni, F; Rickenbach, M; Gutzwiller, Felix (1993). Lipides sanguins dans la population suisse: enquête MONICA 1988-89. Schweizerische Medizinische Wochenschrift (Supplementum), 123(suppl. 48):29-37.

Gutzwiller, Felix; Rickenbach, M; Barazzoni, F; Ackermann-Liebrich, Ursula (1993). Regelmässige Erfassung von Herz-Kreislauf-Risiken und -Krankheiten: sinnvoll oder nicht? (Die MONICA-Erfahrung). Schweizerische Medizinische Wochenschrift (Supplementum), 1993(Suppl. 48):8-12.

Rickenbach, M; Wietlisbach, Vincent; Beretta-Piccoli, C; Moccetti, T; Gutzwiller, Felix (1993). Tabakkonsum, Blutdruck und Körpergewicht in der Schweizer Bevölkerung: MONICA-Studie 1988-89. Schweizerische Medizinische Wochenschrift (Supplementum), 123(Suppl. 48):21-28.

Rickenbach, M; Wietlisbach, Vincent; Barazzoni, F; Gutzwiller, Felix (1992). Hospitalisations pour infarctus du myocarde dans les cantons de Vaud, Fribourg et Tessin: résultats de l'étude MONICA pour la période 1985-1988. Médecine et Hygiène, 50(1920):350-354.

Bertel, O; Darioli, R; Epstein, Fred H; Gutzwiller, Felix; Hartmann, G; Keller, U; Mordasini, R; Noseda, G; Pometta, D; Rickenbach, M; Riesen, W; Rutishauser, W (1992). Lipide und die Prävention der koronaren Herzkrankheit: Diagnostik und Massnahmen : aktualisierte Empfehlungen. Schweizerische Aerztezeitung, 73(42):1593-1602.

Rickenbach, M; Wietlisbach, Vincent; Tullen, B; Gutzwiller, Felix (1990). Les facteurs de risque cardiovasculaire dans la population vaudoise et fribourgeoise : quelques résultats de la deuxième enquête MONICA (1988-89). Tribuna Medica Ticinese, 55(9):538-541.

Marti, Bernard; Dai, S; Rickenbach, M; Wietlisbach, Vincent; Bucher, C; Barazzoni, F; Gutzwiller, Felix (1990). Gesamtcholesterin, HDL-Cholesterin und Blutdruck in Abhängigkeit vom Lebensstil: Ergebnisse der ersten Bevölkerungsstudie des Schweizer MONICA-Projekts. Swiss Medical Weekly, 120(51-52):1976-1988.

Marti, Bernard; Rickenbach, M; Keil, U; Stieber, J; Greiser, E; Herman, B; Heinemann, L; Assmann, A; Schädlich, H; Nüssel, E; Östör-Lamm, E; Gutzwiller, Felix (1990). Variation in coronary risk factor levels of men and women between the German-speaking MONICA centres. Revue d'épidémiologie et de santé publique, 38(5-6):479-486.

Gutzwiller, Felix; Wietlisbach, V; Rickenbach, M (1989). Le cholestérol comme facteur de risque cardiovasculaire dans la population suisse. Médecine et Hygiène, 47(1797):1756-1760.

Perrin-Michon, A C; Wietlisbach, V; Rickenbach, M; Gutzwiller, Felix (1988). Evaluation de la campagne de vaccination contre la poliomyélite de 1985 en Suisse. Médecine et Hygiène, 46(1763):2652-2663.

Janin, B; Burnand, Bernard; Rickenbach, M; Gutzwiller, Felix (1988). Cholestérol et HDL: quelles sont les valeurs critiques pour la Suisse? Médecine et Hygiène, 46:410-415.

Burnand, Bernard; Hausser, Dominique; Rickenbach, M; Platsoukas, C; Gutzwiller, Felix (1988). Cholestérol plasmatique total et HDL dans la population en Suisse; Quelle attitude et quelles normes adopter? Sozial- und Präventivmedizin, 33(1):60-67.

Wietlisbach, V; Rickenbach, M; Burnand, Bernard; Hausser, Dominique; Gutzwiller, Felix (1988). Combining repeated blood pressure measurements to obtain prevalences of high blood pressure. Acta medica Scandinavica. Supplementum, 728:165-168.

Bovet, P; Darioli, R; Janin, B; Rickenbach, M; Gutzwiller, Felix (1988). Dépistage et traitement des facteurs de risque des maladies cardio-vasculaires: nécessité d'une stratégie? Swiss Medical Weekly, 118(48):1797-802.

Bille, J; Glauser, M-P; Méan, F; Aubort, J-D; Nicolet, J; Breer, C; Schällibaum, M; Gutzwiller, Felix; Rickenbach, M (1986). Listeriose : neuere Ergebnisse zur Epidemiologie in der Schweiz. Bulletin des Bundesamtes für Gesundheitswesen, 1986(50):413-414.

Rickenbach, M; Gutzwiller, Felix (1986). Akute virale Hepatitiden : die Statistik der Jahre 1984 und 1985. Bulletin des Bundesamtes für Gesundheitswesen, 1986(47):383-384.

Gutzwiller, Felix; Rickenbach, M; Burnand, Bernard; Hausser, Dominique (1986). Epidémiologie et prévention des maladies cardiovasculaires en Suisse. Schweizerische Rundschau für Medizin PRAXIS, 75(40):1157-1162.

Hausser, D; Burnand, B; Rickenbach, M; Gutzwiller, Felix (1986). MONICA-CH: ses premiers résultats. Médecine et Hygiène, 44(1643):353-357.

Grob, P J; Rickenbach, M; Steffen, Robert; Wagner, Susanne; Kistler, G; Schmid, M; Gutzwiller, Felix (1985). Hepatitis B vaccination campaign in a low endemicity area. European Journal of Clinical Microbiology, 4(4):408-411.

Gutzwiller, Felix; Rickenbach, M; Epstein, Fred H (1985). Primary prevention of essential hypertension - current needs for action and research: summary of a roundtable discussion. Preventive medicine, 14(4):548-552.

Rickenbach, M; Gutzwiller, Felix; Wietlisbach, V; Martin, J; Epstein, Fred H (1985). Switzerland's participation in MONICA. Sozial- und Präventivmedizin, 30(2):95-99.

Rickenbach, M; Frei, Ph C; Grob, P J; Gutzwiller, Felix; Kernen, V; Somaini, Bertino (1984). La vaccination contre l'hépatite B en Suisse. Medecine et Hygiene, 42(1551):445-448.

Rickenbach, M; Gutzwiller, Felix; Epstein, Fred H; Martin, J (1984). Le projet MONICA - Monitoring of trends and determinants in cardiovascular disease. Sozial- und Präventivmedizin, 29(4-5):168.

Grob, P J; Rickenbach, M; Wagner, Susanne; Steffen, Robert; Gutzwiller, Felix (1983). Hepatitis B vaccination of high-risk individuals in the canton of Zurich. European Journal of Clinical Microbiology, 2(4):309-315.

Mächler, R; Steffen, Robert; Schär, Meinrad; Grob, P J; Rickenbach, M; Kernen, V; Frei, Ph; Gutzwiller, Felix; Wagner, Susanne (1983). Hepatitis-B-Impfkampagne im Kanton Zürich 1982/83. Sozial- und Präventivmedizin, 28(5):206-207.

This list was generated on Sat Jul 22 09:01:37 2017 CEST.